VIP1339

N/A

Report date: 2023/05/31 15:47:35

NME

Base Information

Drug NameVIP1339

Drug Alias NameVIP1339VIP-1339

ClassificationSmall molecules

Mechanisms of ActionKinesin-like protein 1 inhibitors

TargetsKinesin-like protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVincerx Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A